During a House Education and Workforce Committee hearing prior to the congressional recess, Rep. Mark DeSaulnier (D-CA) questioned Bethany Lilly, the Executive Director of Public Policy at the Leukemia & Lymphoma Society, about the effects of possible cuts to the National Institutes of Health and the Affordable Care Act.
